Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of metformin prolonged-release on achievement of optimal glycemic control in gestational diabetes: A pilot, randomized, double-blind, clinical trial
TCTR20250525007Phase 3Recruiting
- Sponsor
- Merck & Co.
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of metformin in gestational diabetes mellitus (GDM), sponsored by Merck & Co.. Started Apr 2025; status: recruiting.
02
Drugs
metformin
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on TCTR20250525007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250525007.